Migraine Drug Birth Defect Lawsuits
Migraine headaches are a common and painful health problem. Depakote (divalproex sodium) and Topamax (topiramate) are prescription medications designed to treat migraine headaches by increasing the levels of neurotransmitters in the brain. These medications have been linked to birth defects—including lowered IQs and cleft palates—in the children of women who took the drugs while pregnant.
The Topamax birth defect lawyers at Ferrer, Poirot & Wansbrough want to help people whose children were born with birth defects resulting from prescription medications. If your child was born with birth defects, he or she may require a lifetime of expensive medical treatments and professional care. We want to protect your rights to the compensation you deserve. Call us at (800) 210-8503 or fill out a free initial consultation form.
Depakote and Topamax Side Effects
The New England Journal of Medicine found that children who were exposed to Depakote while in the womb may be at a high risk of developing cognitive birth defects, such as reduced IQ. In addition, the U.S. Food and Drug Administration warns that children who were exposed to Topamax while in the womb may be at risk of developing facial and oral deformities, such as cleft lip and cleft palate.
Children with reduced IQ may have difficulty in school and becoming independent, and children with cleft palates may face social stigma and expensive surgeries. At Ferrer, Poirot & Wansbrough, it’s our goal to stand up for parents of children who were harmed by prescription drugs. We’ve helped countless clients get money for drug injuries, and we can help you, too. Contact us 24/7 and get started on a claim with your free, confidential consultation.
Depakote® is a registered trademark of Abbott Laboratories. Topamax® is a registered trademark of Janssen Pharmaceuticals, Inc.
This law firm is not associated with, sponsored by, or affiliated with The New England Journal of Medicine, the U.S. Food and Drug Administration, Abbott Laboratories, or Janssen Pharmaceuticals, Inc.